Most Recent
Labour hire firm CoreStaff will pay $6.4 million to settle a class action accusing it of using the promise of long-term work to lure workers to Australia from Papua New Guinea, only to terminate their employment agreements less than three years after they made the move.
The NSW Independent Commission Against Corruption has found Holding Redlich managing partner Ian Robertson's account of a meeting where he allegedly advised the former NSW Labor general secretary to cover up a $100,000 illegal political donation "inconceivable", but declined to refer the lawyer for criminal charges or disciplinary action.
Bristol-Myers Squibb unit Celgene has dropped a lawsuit accusing Indian generics company Dr Reddy's Laboraties of threatening to infringe its patent for Revlimid with the planned launch of a generic version of the blockbuster cancer drug in Australia.
The High Court has shot down Greensill founder Lex Greensill's bid for special leave to challenge a finding that he owes tax on $58 million in capital gains, including income from the sale of shares in the collapsed UK-based supply chain finance company.
Noumi, formerly known as Freedom Foods, has agreed to pay $860,000 in Blue Diamond Growers' costs as part of a $48 million settlement of a legal spat over a licensing deal to sell Almond Breeze milk, which the food maker unsuccessfully argued should be heard in Australia.
An appellate victory by insurers in a test case over business interruption coverage for losses stemming from the COVID-19 pandemic does not spell the end to class actions brought on behalf of businesses whose claims were denied, according to a lawyer for the class actions.
BHP Group has been granted special leave from the High Court to appeal a ruling that rejected its bid to exclude foreign investors from a shareholder class action over the 2015 Fundao dam disaster.
The funder that was bankrolling a class action alleging pharmacy giant Priceline exercised an "overly prescriptive level of control" on franchisees which limited their profitability has withdrawn its support for the proceeding.
A new funder is backing a shareholder class action that will be brought against Australian regenerative medicine company Mesoblast over disclosures related to its Remestemcel-L treatment for COVID-19 complications.
The organiser of the Big Red Bash outback music festival has appealed a judgment denying it coverage for $3.2 million cancellation of the festival during the first wave of the coronavirus pandemic